Dmitry BORDIN

Healthcare Institution of Moscow

«Moscow Clinical Scientific Center»
86 shosse Entuziastov, Moscow
111123 Russia

Tel: +7 495 304 9551
Fax:+7 495 304 1942 

E-Mail:dmitrybordin@gmail.com
d.bordin@mknc.ru 

 

Date of birth

03 of December 1970 (Russian Federation)

 

Current Position and Relevant Previous / Other Employment

  • 04.2014 - present

  • Healthcare Institution of Moscow «Moscow Clinical Scientific Center », 86 shosse Entuziastov, Moscow, 111123, Russia
    Head of department of pancreatic, biliary and upper GI disease

  • 04.2012 - present
    Tver States Medical Academy, 4 Sovetskaya st, Tver, 170642, Russia
    Associate professor

  • 09.2006 – 04.2014
    Healthcare Institution of Moscow «Central Research Institute of Gastroenterology», 86 shosse Entuziastov, Moscow, 111123, Russia
    Senior staff scientist

  • 05.2005 – 07.2006
    Ege University, School of Medicine, Sect. Gastroenterology, Izmir, Turkey
    Fellow

  • 09.2003 – 05.2005
    Healthcare Institution of Moscow «Central Research In-stitute of Gastroenterology», 86 shosse Entuziastov, Moscow, 111123, Russia
    Research assistant

  • 09.1999 – 08.2003
    Tver States Medical Academy, 4 Sovetskaya st, Tver, 170642, Russia
    Assistant of the department of Hospital Therapy

 

University and Post-Graduate Education:

  • 09.2008 – 12.2008

  • Russian State Medical University, 1 Ostrovityanova str., 117997, Moscow
    Gastroenterology
    PE No. 30963

  • 09.1994 – 08.1996
    Tver States Medical Academy, 4 Sovetskaya st, Tver, 170642, Russia
    Therapeutist
    No. 130

  • 09.1988 – 06.1994
    Tver States Medical Academy, 4 Sovetskaya st, Tver, 170642, Russia
    Physician
    LV No. 283787

 

Training Courses and Seminars:

Month, YearName of the Course or Certificate Organizer, City, Country

05.2011-05.2011
ICH GCPHealthcare Institution of Moscow «Central Research Institute of Gastroenterology», Moscow, Russia

 

Language Proficiency:

English: Reading, Written, Spoken

 

Clinical trials Experience:

2013 - present

  • European Registry on the management of Helico-bacter pylori infection (“Hp-EuReg”) 
    Local coordinator in Russia

  • 2014 - present
    Gastroenterology LKTZ-OMZ-2-06-12III
    Principal Investigator

  • 2013 - 2014
    Gastroenterology CS-LK01-12III
    Principal Investigator

  • 2012 - 2014
    Gastroenterology EZTN-EB-4-02/11IV
    Principal Investigator

  • 2011 - 2012
    Gastroenterology KCT 26/2009 – PAN-STAR/IV
    Principal Investigator

  • 2009 - 2010
    Gastroenterology VIA APIAIV
    Principal Investigator

  • 2008 - 2009
    Gastroenterology No km 25/2008 - LIEDER/RUIV
    Investigator

  • 2007 - 2008
    Gastroenterology ALUMI L 00697IV
    Investigator

 

Society membership

  • American gastroenterological association (AGA). Member Number: 1001254

  • International society of disease of the esophagus (ISDE)

  • World Organization for Specialized Studies on Diseases of the Esophagus (OESO)

  • European Pancreatic club http://www.e-p-c.org/russian-pancreatic-club

  • Scientific society of Gastroenterology of Russia
     

Publications

Scientific Area: Gastroenterology | Total: 255

  • McNicholl A.G., Gasbarrini A., Tepes B., Bordin D.S., Lerang F., Leja M., Rokkas T., Vaira D., Shvets O., Kupcinskas L., Pérez-Aisa A., Axon A.T., Buzas G.M., Simsek I., Katicic M., Machado J.C., Lamy V., Przytulski K., Boyanova L., Bytzer P., Beglinger C., Capelle L., Goldis A., Veijola L., Vujasinovic M., Huerta A., Perez-Lasala J., Caldas M., Ramas M., Megraud F., O'Morain C.A., Gisbert J.P. Pan-European Registry on H. pylori Management (Hp-EuReg): Interim Analysis of 8,271 Patients. Gastroenterology 2015; 148 (4): S-417

  • McNicholl A.G., Gasbarrini A., Tepes B., Bordin D.S., Lerang F., Leja M., Rokkas T., Vaira D., Shvets O., Kupcinskas L., Pérez-Aisa A., Axon A.T., Buzas G.M., Simsek I., Katicic M., Machado J.C., Lamy V., Przytulski K., Boyanova L., Bytzer P., Beglinger C., Capelle L., Goldis A., Veijola L., Vujasinovic M., Huerta A., Perez-Lasala J., Caldas M., Ramas M., Megraud F., O'Morain C.A., Gisbert J.P. Pan-European Registry on H. pylori Management (Hp-EuReg): Bacterial Resistance. Gastroenterology 2015; 148 (4): S-417

  • McNicholl A.G., Gasbarrini A., Tepes B., Bordin D.S., Lerang F., Leja M., Rokkas T., Vaira D., Shvets O., Kupcinskas L., Pérez-Aisa A., Axon A.T., Buzas G.M., Simsek I., Katicic M., Machado J.C., Lamy V., Przytulski K., Boyanova L., Bytzer P., Beglinger C., Capelle L., Goldis A., Veijola L., Vujasinovic M., Huerta A., Perez-Lasala J., Caldas M., Ramas M., Megraud F., O'Morain C.A., Gisbert J.P. Pan-European Registry on H. pylori Management (Hp-EuReg): Rescue Treatments. Gastroenterology 2015; 148 (4): S-417

  • McNicholl A.G., Gasbarrini A., Tepes B., Bordin D.S., Lerang F., Leja M., Rokkas T., Vaira D., Shvets O., Kupcinskas L., Pérez-Aisa A., Axon A.T., Buzas G.M., Simsek I., Katicic M., Machado J.C., Lamy V., Przytulski K., Boyanova L., Bytzer P., Beglinger C., Capelle L., Goldis A., Veijola L., Vujasinovic M., Huerta A., Perez-Lasala J., Caldas M., Ramas M., Megraud F., O'Morain C.A., Gisbert J.P. Pan-European Registry on H. pylori Management (Hp-EuReg): Safety. Gastroenterology 2015; 148 (4): S-417

  • Mcnicholl A.G., Gasbarrini A., Tepes B., Lerang F., Bordin D.S., Shvets O., Rokkas T., Kupcinskas L., Leja M., Katicic M., Machado J.C., Boyanova L., Przytulski K., Simsek I., Buzas G.M., Axon T., Beglinger C., Bytzer P., Lamy V., Goldis A., Cappelle L.G., Veijola L., Caldas M., Ramas M., Megraud F., O’Morain C.A., Gisbert J.P. on behalf of the Hp-EuReg investigators and, the European Helicobacter Study Group. Pan-European Registry on H. pylori Management: Interim Analysis of 5,000 Patients. United European Gastroenterology Journal 2014;2(S.1): A36

  • Bordin D.S., Yanova O.B., Berezina O.I., Treyman E.V., Gasieva O.U. Efficacy of combination pantoprazole with alginate-antacids for symptoms control at first week of GERD treatment. Diseases of the Esophagus 2014;27(Suppl.1):24A

  • Burkov S.G., Bordin D.S., Markina N.F., Sharapova E. I. Influence of H. pylori infection on pregnancy. Helicobacter 2014;19(1):115

  • McNicholl A. G., Gasbarrini A., Tepes B., Lerang F., Bordin D. S., Shvets O., Rokkas T., Kupcinskas L., Leja M., Katicic M., Machado J. C., Boyanova L., Przytulski K., Simsek I., Buzas G. M., Axon T., Beglinger C., Bytzer P., Lamy V., Goldis A., Cappelle L. G., Veijola L., Caldas M., Ramas M., Megraud F., O'Morain C. A., Gisbert J. P., on Behalf of the Hp-EuReg investigators and the European Helicobacter Study Group; Pan-European Registry on H. pylori Management (Hp-EuReg): First-Line Treatments. Helicobacter 2014;19(1):129

  • McNicholl A. G., Gasbarrini A., Tepes B., Lerang F., Bordin D. S., Shvets O., Rokkas T., Kupcinskas L., Leja M., Katicic M., Machado J. C., Boyanova L., Przytulski K., Simsek I., Buzas G. M., Axon T., Beglinger C., Bytzer P., Lamy V., Goldis A., Cappelle L. G., Veijola L., Caldas M., Ramas M., Megraud F., O'Morain C. A., Gisbert J. P., on Behalf of the Hp-EuReg investigators and the European Helicobacter Study Group; Pan-European Registry on H. pylori Management (Hp-EuReg): Interim Analysis of 5,792 Patients. Helico-bacter 2014;19(1):79

  • McNicholl A. G., Gasbarrini A., Tepes B., Lerang F., Bordin D. S., Shvets O., Rokkas T., Kupcinskas L., Leja M., Katicic M., Machado J. C., Boyanova L., Przytulski K., Simsek I., Buzas G. M., Axon T., Beglinger C., Bytzer P., Lamy V., Goldis A., Cappelle L. G., Veijola L., Caldas M., Ramas M., Megraud F., O'Morain C. A., Gisbert J. P., on Behalf of the Hp-EuReg investigators and the European Helicobacter Study Group; Pan-European Registry on H. pylori Management (Hp-EuReg): Rescue Treatments. Helicobacter 2014;19(1):130

  • McNicholl A. G., Gasbarrini A., Tepes B., Lerang F., Bordin D. S., Shvets O., Rokkas T., Kupcinskas L., Leja M., Katicic M., Machado J. C., Boyanova L., Przytulski K., Simsek I., Buzas G. M., Axon T., Beglinger C., Bytzer P., Lamy V., Goldis A., Cappelle L. G., Veijola L., Caldas M., Ramas M., Megraud F., O'Morain C. A., Gisbert J. P., on Behalf of the Hp-EuReg investigators and the European Helicobacter Study Group. Pan-European Registry on H. pylori Management (Hp-EuReg): Safety. Helicobacter 2014;19(1):136

  • Blackshaw LA, Bordin DS, Brock C, Brokjaer A, Drewes AM, Farmer AD, Krarup AL, Lottrup C, Masharova AA, Moawad FJ, Olesen AE. Pharmacologic treatments for esophageal disorders. Ann N Y Acad Sci. 2014 Sep;1325:23-39. doi: 10.1111/nyas.12520.

  • Bordin DS. The acid pocket as the pathogenic basis and therapeutic target in gastroesophageal reflux disease. Ter Arkh. 2014;86(2):76-81.

  • Lazebnik LB, Bordin DS; Research Group "Parad". Management of patients with Helicobacter pylori-related illness in the ordinary clinical practice. Intermediate results of monitoring program. Eksp Klin Gastroenterol. 2013;(5):93-101.

  • Bordin D.S., Berezina O.I., Kim V.A., Orobey Yu.A., Patrushev N.B. Diagnosis of Helicobacter pylori infec-tion in routine clinical practice in Russia. Helicobacter 2013;18:122

  • Bordin D.S., Berezina O.I., Kim V.A., Patrushev N.B., Orobey Yu.A. Quadruple therapy with PPI, bismuth, josamycine and amoxicillin. Preliminary results of the observational program. Helicobacter 2013;18:133

  • Lazebnik LB, Tkachenko EI, Abdulkhakov RA, Bordin DS, Grinevich VB, Livzan MA, Minushkin ON, Osipenko MF, Pasechnikov VD, Radchenko VG, Rustamov MN, Saĭfutdinov RG, Samsonov AA, Sarsenbaeva AS, Sitkin SI, Simanenkov VB, Starostin BD, Iakovenko ÈP. Standards for diagnosis and treatment of acid and Helicobacter pylori-associated diseases. Eksp Klin Gastroenterol. 2013;(5):3-11.

  • Russian Scientific Society of Gastroenterologists, Bordin DS. Recommendations of the Russian Scientific Society of Gastroenterologists on the diagnostics and treatment of chronic pancreatitis (adopted at the 11th Congress of the RSSG, March 2, 2011, at the meeting of Russian Pancreatic Club). Eksp Klin Gastroenterol. 2011;(7):122-9.

  • Bordin DS, Masharova AA, Lazebnik LB. From the results of the "MEGRE" study to the "Society against heartburn" project. Eksp Klin Gastroenterol. 2011;(2):15-21.

  • Lazebnik LB, Masharova AA, Bordin DS, Vasil'ev IuV, Tkachenko EI, Abdulkhakov RA, Butov MA, Eremina EIu, Zinchuk LI, Tsukanov VV. Results of a multicenter trial "Epidemiology of Gastroesophageal Reflux Disease in Russia" (MEGRE). Ter Arkh. 2011;83(1):45-50.

  • Bordin DS. Diagnostic and treatment of gastroesophageal reflux disease. Eksp Klin Gastroenterol. 2011;(8):55-8.

  • Lazebnik LB, Bordin DS, Mikheeva OM, Belousova NL. Eradication efficiency and Helicobacter pylori resistance to antibiotics in anticipation of IV TH Maastricht consensus issues publication. Editorial. Eksp Klin Gastroenterol. 2011;(8):3-7.

  • Lazebnik L.B., Bordin D. S., Belousova N.L., Masharova A. A., Zelenikin S.A. frequency of site-specific mutations in the 23S rRNA gene of Helicobacter pylori in Moscow. Helicobacter 2011;16:121

  • Lazebnik LB, Bordin DS, Masharova AA, V'iuchnova ES, Zakharova NV, Abdulkhakov RA, Prokhorova LV, Nikolaeva NN. Lanzoptol efficacy at gastroesophageal reflux disease: results of multicenter study “Leader”. Eksp Klin Gastroenterol. 2010;(7):112-20.

  • Lazebnik LB, Bordin DS, Masharova AA, Dzhulaĭ GS, Butov MA, Abdulkhakov RA, Eremina EIu, Tarasova LV, Safonova OV, Firsova LD, Kozhurina TS. Restoration of the quality of life by eliminating and prevention of heartburn by alginate: results of multicenter study "VIA APIA". Eksp Klin Gastroenterol. 2010;(6):70-6.

  • Bordin DS. How to choose correct proton pump inhibitors to patients with GERD? Eksp Klin Gastroenterol. 2010;(2):53-8.

  • Bordin DS, Masharova AA, Droxzdov VN, Firsova LD, Kozhurina TS. Diagnostic value of alginate test in gastroesophageal reflux disease. Eksp Klin Gastroenterol. 2010;(12):102-7.

  • Lazebnik LB, Masharova AA, Vasnev OS, Bordin DS, Valitova ÉR, Ianova OB. Gastroesophageal reflux disease in the elderly patients: epidemiology, clinical features, therapy. Eksp Klin Gastroenterol. 2010;(12):10-6.

  • Valitova ER, Bordin DS, Ianova OB, Vasnev OS, Masharova AA. Functional methods of the esophagus examination. Eksp Klin Gastroenterol. 2010;(10):71-4.

  • Bordin DS, Masharova AA, Sil'vestrova SIu, Firsova LD, Safonova OV, Petrakov AV, Kozhurina TS, Valitova ER, Ianova OB. Pharmacokinetics of the proton pump inhibitors and psychological status in patients as factors that influence the efficiency of treatment of GERD with pantoprazole. Eksp Klin Gastroenterol. 2010;(9):90-6.

  • Lazebnik L. B., Masharova A. A., Bordin D. S., Khomeriki S.G. Influence of Bismuth on gastritis healing and effectiveness of Helicobacter pylori eradication. Helicobacter 2010;15:343

  • Lazebnik LB, Bordin DS, Masharova AA. Prolonged therapy with proton pump inhibitors: balance of benefits and risks. Eksp Klin Gastroenterol. 2010;(9):3-8.

  • Lazebnik L. B., Bordin D. S., Masharova A. A. Bismuth improves the effectiveness of H. pylori eradication. Helicobacter 2009;14:401

  • Bordin DS, Masharova AA, Firsova LD, Kozhurina TS, Safonova OV. Evaluation of action, efficacy, and onset dynamics of a single dose of alginates in patients with heartburn and GERD. Eksp Klin Gastroenterol. 2009;(4):77-85.

  • Bordin DS, Masharova AA, Lazebnik LB. Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review). Eksp Klin Gastroenterol. 2008;(4):36-8.

  • Lazebnik LB, Masharova AA, Bordin DS, Vasil'ev IuV, Tkachenko EI, Abdulkhakov RA, Butov MA, Eremina EIu, Zinchuk LI, Tsukanov VV. Multicentre study "Epidemiology of gastroesophageal reflux disease in Russia"(MEGRE): first results. Eksp Klin Gastroenterol. 2009;(6):4-12.

  • Lazebnik L.B., Masharova A.A., Bordin D.S., Firsova L.D., Zelenikin S.A. Prevalence and significance of H. pylori in patients with gastroesophageal reflux disease. Helicobacter 2008;13:442-443

  • Lazebnik LB, Bordin DS, Masharova AA. Society against heartburn. Eksp Klin Gastroenterol. 2007;(4):5-10.

  • Lazebnik LB, Bordin DS, Masharova AA. Modern concept of gastroesofageal reflux disease: from Genvaal to Monreal. Eksp Klin Gastroenterol. 2007;(5):4-10.

  • Bordin DS, Masharova AA, Firsova LD, Kozhurina TS, Safonova OV. Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease. Eksp Klin Gastroenterol. 2008;(6):77-81.

  • Bordin DS, Bor S. Clinical value of esophagus manometry. Eksp Klin Gastroenterol. 2006;(6):25-34.

  • Bordin DS, Bor S, Vasilev IuV. Methodology and possibilities of manometry in the diagnosis of esophageal disease. Ter Arkh. 2007;79(4):63-71.

EHMSG Core Agency

WMA GmbH

Alser Strasse 4, 1090 Vienna, Austria

Contact

Tel.: +43 1 405 13 83 18

Fax: +43 1 405 13 83 918

© 2019

EHMSG c/o WMA GmbH

  • zwitschern

Follow us on Twitter

The EHMSG is a member of the United European Gastroenterology, a professional non-profit organisation combining all the leading European societies concerned with digestive disease.
UEG represents over 22,000 specialists, working across medicine, surgery, paediatrics, GI oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge.